References

Almdal T et al. Arch Intern Med 2004 ; 164(13): 1422-1426.
Blankenhorn DH et al. Ann Intern Med 1993;119(10):969-976.
Brown BG et al. N Engl J Med 1990;323(19):1289-1298.
Cannon C et al. N Engl J Med 2004;350:1495-1504.
Cholesterol Treatment Collaborators (CTT), Lancet 2005; 366: 1267-1278.
Chu B et al. Stroke 2004;8:2444-2448.
Deedwania PC. Am J Med 1998; 105(1A); 1S-3S.
European Cardiovascular Disease Statistics 2008 Edition, British Heart Foundation
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001: 285; 2486-2497
EUROASPIRE II Study Group. Eur Heart J 2001;22:554-572.
Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehab 2007; 14: S1-S113.
Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehab 2007; 14: E1-E40.
Grundy SM et al. Circulation 2004;110:227-239.
Heart Protection Study Collaborative Group. Lancet 2002;360:7-22.
In: Fast Facts - Hyperlipidaemia. Eds Durrington P, Sniderman A. Health Press Ltd, Oxford, 2000. 1-17.
In: Fast Facts - Hyperlipidaemia. Eds Durrington P, Sniderman A. Health Press Ltd, Oxford, 2000. 81-94
In: Fast Facts - Hyperlipidaemia. Eds Durrington P, Sniderman A. Health Press Ltd, Oxford, Second Edition, 2002. 7-12.
In: Manual of Lipid Disorders, 2nd Edition. Eds Gotto A, Pownall H. Williams & Wilkins, US, 1999. 2-10.
International Cardiovascular Disease Statistics 2005; American Heart Association.
Kannel MD et al. Am Heart J 1986; 112(4); 825-836.
Kastelein JJP et al. Am Heart J 2005;149:234-239.
LaRosa JC et al. N Engl J Med 2005; 352: 1425-1435.
Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-41.
MAAS Investigators. Lancet 1994;344:633-638.
Nissen SE, Yock P. Circulation 2001;103:604–616.
Nissen S. JAMA 2004;291:1071-1080.
Ott C, Schmieder RE. Curr Hypertens Rep. 2009 Apr;11:143-149.
Pearson TA et al. Arch Intern Med 2000;160:459-467
Phillips B et al. Br J Cardiol 2007; 14:280-285..
Pitt B et al. J Am Coll Cardiol 1995;26(5):1133-1139.
Sacks FM et al, for the Cholesterol and Recurrent Event Trial Investigators. N Engl J Med 1996;335:1001-1009.
Senior V et al. Cardiovascular Drugs and Therapy 2004; 18: 475-481.
Sever PS et al. Lancet 2003;361:1149-1158.
Shepherd J et al, for the West of Scotland Coronary Prevention Study (WOSCOPS) Group. N Engl J Med 1995;333:1301-1307.
Shepherd J et al. Diabetes Care 2006; 29:1220-1226.
The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-1357.
The Scandinavian Simvastatin Survival Study Group. Lancet 1994;344:1383–1389.
The SPARCL Investigators N Engl J Med 2006; 355: 549-559.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Full report. Section III-1. NIH Publication No. 02-5215, September 2002. This guideline document, published by the National Heart, Lung, and Blood Institute (NHLBI), as a part of the NIH and the U.S. Department of Health and Human Services, is available at: www.nhlbi.nih.gov/guidelines/cholesterol.
Truong QA et al. JACC Cardiovasc Imaging 2008;1(6):772-781.
Waters D et al. Circulation 1994;89(3):959-968.
Wood D et al, for the Joint European Committee, Second Task Force of European and other Societies. Atherosclerosis 1998; 140: 199-270.
World Health Report 2004. World Health Organization. http:/anti-infectives/Paris-Event/Live-Webcast.cfmwww.who.int.
World Health Organization. The World Health Report 2002.
Yeshurun D, Gotto AM. Southern Med J 1995; 88(4): 379-391.